Patient characteristics in Behçet’s Syndrome and their associations with major organ involvement: a single-centre experience of 2118 cases

References

• Yazici H, Seyahi E, Hatemi G, Yazici Y. Behçet syndrome: a contemporary view. Nat Rev Rheumatol 2018;14:107–19.
   PubMed Web of Science ®Google Scholar
• Akkoç N. Update on the epidemiology, risk factors and disease outcomes of Behçet’s disease. Best Pract Res Clin Rheumatol 2018;32:261–70.
   PubMed Web of Science ®Google Scholar
• Ozguler Y, Leccese P, Christensen R, Esatoglu SN, Bang D, Bodaghi B, et al. Management of major organ involvement of Behçet’s syndrome: a systematic review for update of the EULAR recommendations. Rheumatology (Oxford) 2018;57:2200–12.
   PubMed Web of Science ®Google Scholar
• Tursen U, Gurler A, Boyvat A. Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet’s disease. Int J Dermatol 2003;42:346–51.
   PubMed Web of Science ®Google Scholar
• Davatchi F, Shahram F, Chams H, Nadji A, Jamshidi AR, Chams C, et al. The influence of gender on the severity and the outcome of ocular lesions in Behçet’s disease. Adv Exp Med Biol 2003;528:67–71.
   PubMed Web of Science ®Google Scholar
• Ugurlu N, Bozkurt S, Bacanli A, Akman-Karakas A, Uzun S, Alpsoy E. The natural course and factors affecting severity of Behçet’s disease: a single-center cohort of 368 patients. Rheumatol Int 2015;35:2103–7.
   PubMed Web of Science ®Google Scholar
• Ishido T, Horita N, Takeuchi M, Kawagoe T, Shibuya E, Yamane T, et al. Clinical manifestations of Behçet’s disease depending on sex and age: results from Japanese nationwide registration. Rheumatology (Oxford) 2017;56:1918–27.
   PubMed Web of Science ®Google Scholar
• Gheita TA, El-Latif EA, El G II, Samy N, Hammam N, Abdel Noor RA, et al. Behçet’s disease in Egypt: a multicenter nationwide study on 1526 adult patients and review of the literature. Clin Rheumatol 2019;38:2565–75.
   PubMed Web of Science ®Google Scholar
• Li C, Li L, Wu X, Shi J, Liu J, Zhou J, et al. Clinical manifestations of Behçet’s disease in a large cohort of Chinese patients: gender- and age-related differences. Clin Rheumatol 2020;39:3449–54.
   PubMed Web of Science ®Google Scholar
• Ryu HJ, Seo MR, Choi HJ, Baek HJ. Clinical phenotypes of Korean patients with Behcet disease according to gender, age at onset, and HLA-B51. Korean J Intern Med 2018;33:1025–31.
   PubMed Web of Science ®Google Scholar
• Bonitsis NG, Luong Nguyen LB, LaValley MP, Papoutsis N, Altenburg A, Kötter I, et al. Gender-specific differences in Adamantiades-Behçet’s disease manifestations: an analysis of the German registry and meta-analysis of data from the literature. Rheumatology (Oxford) 2015;54:121–33.
   PubMed Web of Science ®Google Scholar
• Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, et al. 2018 update of the EULAR recommendations for the management of Behçet’s syndrome. Ann Rheum Dis 2018;77:808–18.
   PubMed Web of Science ®Google Scholar
• Criteria for diagnosis of Behçet’s disease. International Study Group for Behçet’s Disease. Lancet 1990;335:1078–80.
   PubMed Web of Science ®Google Scholar
• Karaca M, Hatemi G, Sut N, Yazici H. The papulopustular lesion/arthritis cluster of Behçet’s syndrome also clusters in families. Rheumatology (Oxford) 2012;51:1053–60.
   PubMed Web of Science ®Google Scholar
• Kalra S, Silman A, Akman-Demir G, Bohlega S, Borhani-Haghighi A, Constantinescu CS, et al. Diagnosis and management of Neuro-Behçet’s disease: international consensus recommendations. J Neurol 2014;261:1662–76.
   PubMed Web of Science ®Google Scholar
• Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y. Behçet disease: evolution of clinical manifestations. Medicine 2011;90:125–32.
   PubMed Web of Science ®Google Scholar
• Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, et al. The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine 2003;82:60–76.
   PubMed Web of Science ®Google Scholar
• Hamuryudan V, Hatemi G, Tascilar K, Sut N, Ozyazgan Y, Seyahi E, et al. Prognosis of Behcet’s syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial. Rheumatology (Oxford) 2010;49:173–7.
   PubMed Web of Science ®Google Scholar
• Alpsoy E, Donmez L, Onder M, Gunasti S, Usta A, Karincaoglu Y, et al. Clinical features and natural course of Behçet’s disease in 661 cases: a multicentre study. Br J Dermatol 2007;157:901–6.
   PubMed Web of Science ®Google Scholar
• Yazici H, Tüzün Y, Pazarli H, Yurdakul S, Ozyazgan Y, Ozdoğan H, et al. Influence of age of onset and patient’s sex on the prevalence and severity of manifestations of Behçet’s syndrome. Ann Rheum Dis 1984;43:783–9.
   PubMed Web of Science ®Google Scholar
• Atasoy M, Karatay S, Yildirim K, Kadi M, Erdem T, Senel K. The relationship between serum prolactin levels and disease activity in patients with Behcet’s disease. Cell Biochem Funct 2006;24:353–6.
   PubMed Web of Science ®Google Scholar
• Yavuz S, Ozilhan G, Elbir Y, Tolunay A, Eksioglu-Demiralp E, Direskeneli H. Activation of neutrophils by testosterone in Behçet’s disease. Clin Exp Rheumatol 2007;25:S46–51.
   PubMed Web of Science ®Google Scholar
• Yavuz S, Akdeniz T, Hancer V, Bicakcigil M, Can M, Yanikkaya-Demirel G. Dual effects of testosterone in Behcet’s disease: implications for a role in disease pathogenesis. Genes Immun 2016;17:335–41.
   PubMed Web of Science ®Google Scholar
• Cho YJ, Kim WK, Lee JH, Byeon SH, Koh HJ, Kwon OW, et al. Visual prognosis and risk factors for korean patients with behcet uveitis. Ophthalmol J Intl d’ophtalmologie Int J Ophthalmol Z Augenheilkunde 2008;222:344–50.
   Web of Science ®Google Scholar
• Yazici H, Başaran G, Hamuryudan V, Hizli N, Yurdakul S, Mat C, et al. The ten-year mortality in Behçet’s syndrome. Br J Rheumatol 1996;35:139–41.
   PubMedGoogle Scholar
• McRobbie H, Hajek P, Gillison F. The relationship between smoking cessation and mouth ulcers. Nicotine Tob Res 2004;6:655–9.
   PubMed Web of Science ®Google Scholar
• Marakoğlu K, Sezer RE, Toker HC, Marakoğlu I. The recurrent aphthous stomatitis frequency in the smoking cessation people. Clin Oral Investig 2007;11:149–53.
   PubMed Web of Science ®Google Scholar
• İris M, Özçıkmak E, Aksoy A, Alibaz-Öner F, İnanç N, Ergun T, et al. The assessment of contributing factors to oral ulcer presence in Behçet’s disease: dietary and non-dietary factors. Eur J Rheumatol 2018;5:240–3.
   PubMed Web of Science ®Google Scholar
• Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V. One year in review 2019: Behçet’s syndrome. Clin Exp Rheumatol 2019;37 Suppl 121:3–17.
   PubMed Web of Science ®Google Scholar
• Lee YB, Lee JH, Lee SY, Lee JH, Yu DS, Han KD, et al. Association between smoking and Behçet’s disease: a nationwide population-based study in Korea. J Eur Acad Dermatol Venereol 2019;33:2114–22.
   PubMed Web of Science ®Google Scholar
• Malek Mahdavi A, Khabbazi A, Yaaghoobian B, Ghojazadeh M, Agamohammadi R, Kheyrollahiyan A, et al. Cigarette smoking and risk of Behcet’s disease: a propensity score matching analysis. Mod Rheumatol 2019;29:633–9.
   PubMed Web of Science ®Google Scholar
• Harel-Meir M, Sherer Y, Shoenfeld Y. Tobacco smoking and autoimmune rheumatic diseases. Nat Clin Pract Rheumatol 2007;3:707–15.
   PubMedGoogle Scholar
• Roelsgaard IK, Ikdahl E, Rollefstad S, Wibetoe G, Esbensen BA, Kitas GD, et al. Smoking cessation is associated with lower disease activity and predicts cardiovascular risk reduction in rheumatoid arthritis patients. Rheumatology (Oxford) 2020;59:1997–2004.
   PubMed Web of Science ®Google Scholar
• Zhang YJ, Zhang L, Huang XL, Duan Y, Yang LJ, Wang J. Association between cigarette smoking and impaired clinical symptoms in systemic sclerosis: a review. Cell Immunol 2017;318:1–7.
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Ando M, Katsuno T, Tsuboi N, Maruyama S. Smoking Is a risk factor for relapse of antimyeloperoxidase antibodies-associated vasculitis. J Clin Rheumatol 2018;24:361–7.
   PubMed Web of Science ®Google Scholar
• McDermott G, Fu X, Stone JH, Wallwork R, Zhang Y, Choi HK, et al. Association of cigarette smoking with antineutrophil cytoplasmic antibody-associated vasculitis. JAMA Intern Med 2020;180:870–6.
   PubMed Web of Science ®Google Scholar
• Mohammad AJ, Segelmark M. Association of cigarette smoking with organ damage in primary systemic vasculitis. Scand J Rheumatol 2011;40:51–6.
   PubMed Web of Science ®Google Scholar
• Berti A, Matteson EL, Crowson CS, Specks U, Cornec D. Risk of cardiovascular disease and venous thromboembolism among patients with incident ANCA-associated vasculitis: a 20-year population-based cohort study. Mayo Clin Proc 2018;93:597–606.
   PubMed Web of Science ®Google Scholar
• Chen H, Zhang Y, Li C, Wu W, Liu J, Zhang F, et al. Coronary involvement in patients with Behçet’s disease. Clin Rheumatol 2019;38:2835–41.
   PubMed Web of Science ®Google Scholar
• Aramaki K, Kikuchi H, Hirohata S. HLA-B51 and cigarette smoking as risk factors for chronic progressive neurological manifestations in Behçet’s disease. Mod Rheumatol 2007;17:81–2.
   PubMedGoogle Scholar
• Bilgin AB, Turkoglu EB, Ilhan HD, Unal M, Apaydin KC. Is smoking a risk factor in Ocular Behçet disease? Ocul Immunol Inflamm 2015;23:283–6.
   PubMed Web of Science ®Google Scholar